Reshma Kewalramani
Vermogen: 21 M $ op 31-05-2026
Vermogen: 21 M $ op 31-05-2026
Reshma Kewalramani is President, Chief Executive Officer & Director bij Vertex Pharmaceuticals, Inc. In het verleden was zij VP-Global Clinical Development & Nephrology bij Amgen, Inc. Zij behaalde een doctoraat aan de Boston University School of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-03-2026 | 47.800 ( 0,02% ) | 21 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Algemeen Directeur | 01-04-2020 |
| ALPINE IMMUNE SCIENCES, INC. | President | 20-05-2024 |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Directeur/Bestuurslid | 03-08-2021 |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Directeur/Bestuurslid | - |
Biomedical Sciences Careers Program, Inc. | Directeur/Bestuurslid | - |
Year Up, Inc.
Year Up, Inc. Miscellaneous Commercial ServicesCommercial Services Provides educational and professional development programs | Directeur/Bestuurslid | 18-09-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| GINKGO BIOWORKS HOLDINGS, INC. | Directeur/Bestuurslid | 13-06-2024 |
| AMGEN INC. | Corporate Officer/Principal | 01-01-2017 |
| GINO BIOW | Directeur/Bestuurslid | - |
| ░░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Biomedical Sciences Careers Program, Inc. | |
Year Up, Inc.
Year Up, Inc. Miscellaneous Commercial ServicesCommercial Services Provides educational and professional development programs | Commercial Services |
Boston University School of Medicine
Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Technology Services |
Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Kidney Health Initiative | |
Soaring Eagle Acquisition Corp.
Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. Medical/Nursing ServicesHealth Services Develops biological engineering products and custom microbes | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau